Select Committee on European Union Minutes of Evidence


Supplementary memorandum by Dr Rafael Matesanz

  After coming back to Madrid, I was thinking about the possibility to add something to the inquiry, as you suggested. Here is a paper[1] which I think can help to summarize many of the question posed during the session held in Westminster. With respect to the central point: Why a EU directive? I would like to add something to what was expressed last Thursday.

  In my opinion, the point for countries like UK, Spain, France, Germany and some other should be instead: EU directive: why not? Provided the Commission has assured a "soft" directive with basic requirements about the quality and safety of organ transplantations, none of these western EU countries which in fact are the leaders in this field and are already working with high standards (surely much higher than those which probably will be required for a common agreement) should be reluctant to this initiative (at least I cannot see any future danger in this sense). This is not the case however for many emerging countries in the EU which are in fact very far from these standards and which would benefit a lot from this initiative, and furthermore from the Action Plan which will go together. Yesterday we had a meeting in Madrid about the DOPKI project (with very significant contributions from UK) and I guess that this "European Process" is and will be very positive for organ donation and transplantation in the whole Union.

  Everybody agrees that a common organ EU sharing system has no sense, out of very specific cases, but the establishment of very basic organisational rules which assure for all the EU citizens an access to these therapies and minimum common standards can be very helpful and contribute to save many lives. I would remark the especial importance that for all the recently (and not so recently) admitted countries have all these projects and how negative would be not to continue. The differences registered in this field both from a qualitative and quantitative point of view (from 35 to < 1 donors) are really not acceptable in a common political space like the EU because they mean differences in the possibilities of access of our citizens. I guess it is in our hands try to find a solution.

  Hope these reflections can help the Committee in its important job.






1   Matesanz R and Dominguez-Gil B. Strategies to optimize deceased organ donation, Transplantation Reviews 21 (2007) 177-188 Back


 
previous page contents

House of Lords home page Parliament home page House of Commons home page search page enquiries index

© Parliamentary copyright 2008